'Gilead strikes licensing agreements w 5 cos (Cipla Ltd., Ferozsons Laboratories, Hetero Labs Ltd., Jubilant Lifesciences and Mylan) to manufacture remdesivir in 127 countries, royalty-free until WHO declares end of global public health emergency' -Tweet
Benzinga Newsdesk